“I don’t know if she’s another Steve Jobs,” said Jerry Yeo, professor of pathology at the University of Chicago and director of the Clinical Chemistry Laboratories there. “You have to subject yourself to peer review. You can’t just go in a stealthy mode and then announce one day that you’ve got technology that’s going to disrupt the world.”
Professor Yeo said that he and his colleagues wanted to see data and testing in independent labs. “We have a small army of people ready and willing to test Theranos’s products if they’d ask us,” he said. “And that can be done without revealing any trade secrets.” [1]
[1] http://www.nytimes.com/2015/10/30/business/the-narrative-fra...
It's not unusual for independent testing to show effects significantly smaller than those reported in the clinical trials that lead to FDA approval.
Sometimes the results approach placebo levels.